Vir Biotechnology's total assets for Q2 2026 were $1.21B, an increase of 18.45% from the previous quarter. MX:VIR total liabilities were $232.31M for the fiscal quarter, a 9.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.